Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing
To get patent expiration dates for several products
— Industrial pharmacist, India
To check antibiotic drug patent information
— Pharmacist, Denmark
To get information on expired patents
— Patent Attorney, USA
To get information on brands we work on currently or could potentially work on
— Marketing professional, USA
To study crossover potential for veterinary medicine
— Chief medical officer, USA
Generated: May 24, 2017
| Patents: | 26 |
| Tradenames: | 2 |
| Ingredients: | 2 |
| NDAs: | 2 |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | RX | Yes | Yes | 8,546,372 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | RX | Yes | Yes | 8,617,594 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | RX | Yes | Yes | 8,377,920 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | RX | Yes | Yes | 8,357,677 | ► Subscribe | ► Subscribe | ||||||||||||||||||
Amarin Pharms | VASCEPA | icosapent ethyl | CAPSULE;ORAL | 202057-001 | Jul 26, 2012 | RX | Yes | Yes | 8,426,399 | ► Subscribe | ► Subscribe | ||||||||||||||||||
| This preview shows a limited data set Subscribe for full access, or try a Trial | |||||||||||||||||||||||||||||
Export unavailable in trial.
Subscribe for complete access.
To check antibiotic drug patent information
— Pharmacist, Denmark
For information on patented drugs and their generic versions
— Policy analyst, South Africa
For information about drug approval and launch of NCEs and generic drugs manufactured by India
— Pharmacist
To get paragraph IV challenges, detailed regulatory status and tentative approvals
— Dosage form R&D services company, India
For patent information on systemic antifungals
— Portfolio specialist, USA
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639
Follow DrugPatentWatch:
